
1. Eur Respir J. 2019 May 30;53(5). pii: 1802053. doi: 10.1183/13993003.02053-2018. 
Print 2019 May.

Recognition of CD8+ T-cell epitopes to identify adults with pulmonary
tuberculosis.

Lancioni C(1), Swarbrick GM(1)(2), Park B(3), Nyendak M(4), Nsereko M(5),
Mayanja-Kizza H(5)(6), Null MD(1), Cansler ME(1), Duncan RB(1), Baseke J(5),
Chervenak K(7), Malone L(7), Heaphy EG(7), Boom WH(7), Lewinsohn DM(1)(2)(8),
Lewinsohn DA(1)(8).

Author information: 
(1)Dept of Pediatrics, Oregon Health and Science University, Portland, OR, USA.
(2)Division of Pulmonary and Critical Care Medicine, Oregon Health and Science
University/ Portland VA Medical Center, Portland, OR, USA.
(3)Dept of Biostatistics, Oregon Health and Science University, Portland, OR,
USA.
(4)Dept of Medicine, Division of Infectious Disease, Oregon Health and Science
University, Portland, OR, USA.
(5)Uganda-CWRU Research Collaboration, Kampala, Uganda.
(6)Dept of Medicine, Makerere University, Kampala, Uganda.
(7)Tuberculosis Research Unit, Case Western Reserve University, Cleveland, OH,
USA.
(8)Both authors contributed equally to this manuscript.

DOI: 10.1183/13993003.02053-2018 
PMCID: PMC7055653
PMID: 30923183  [Indexed for MEDLINE]

Conflict of interest statement: Conflict of interest: C. Lancioni has nothing to 
disclose. Conflict of interest: G.M. Swarbrick is an employee of ViTi, Inc, a
company that may have commercial interest in the results of this research. This
potential conflict has been reviewed and managed by OHSU. Conflict of interest:
B. Park has nothing to disclose. Conflict of interest: M. Nyendak reports other
from ViTi, Inc., outside the submitted work; Required language from OHSU: OHSU
and M. Nyendak have a financial interest in ViTi, a company that may have a
commercial interest in the results of this research and technology. These
potential individual and institutional conflicts of interest have been reviewed
and managed by OHSU. Conflict of interest: M. Nsereko has nothing to disclose.
Conflict of interest: H. Mayanja-Kizza has nothing to disclose. Conflict of
interest: M.D. Null is an employee of ViTi, Inc, a company that may have
commercial interest in the results of this research. This potential conflict has 
been reviewed and managed by OHSU. Conflict of interest: M.E. Cansler is an
employee of ViTi, Inc, a company that may have commercial interest in the results
of this research. This potential conflict has been reviewed and managed by OHSU. 
Conflict of interest: R.B. Duncan has nothing to disclose. Conflict of interest: 
J. Baseke has nothing to disclose. Conflict of interest: K. Chervenak has nothing
to disclose. Conflict of interest: L. Malone has nothing to disclose. Conflict of
interest: E.G. Heaphy has nothing to disclose. Conflict of interest: W.H. Boom
reports grants from NIH/NIAID, during the conduct of the study. Conflict of
interest: D.M. Lewinsohn reports grants from NIH (HHSN272200900053C), grants from
NIH (NO1-AI-95383 and HHSN266200700022C/NO1-AI-70022), other from Papé Family
Research Institute, during the conduct of the study; other from ViTi Inc.,
outside the submitted work; OHSU and D.M. Lewinsohn have a financial interest in 
ViTi, a company that may have a commercial interest in the results of this
research and technology. These potential individual and institutional conflicts
of interest have been reviewed and managed by OHSU. Conflict of interest: D.A.
Lewinsohn reports grants from NIH (HHSN272200900053C), grants from NIH
(NO1-AI-95383 and HHSN266200700022C/NO1-AI-70022), other from Papé Family
Research Institute (OHSU institutional funds), during the conduct of the study;
other from ViTi Inc., outside the submitted work; OHSU and D.A Lewinsohn have a
financial interest in ViTi, a company that may have a commercial interest in the 
results of this research and technology. These potential individual and
institutional conflicts of interest have been reviewed and managed by OHSU.

